Atlas Trials

Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)

Clinical trial NCT00116935 · COMPLETED

Trial details

NCT number
NCT00116935
Sponsor
Scandinavian Sarcoma Group
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Sarcoma
Start date
2004-02-01
Primary completion
2010-12-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.